Literature DB >> 676741

The absence of factor II in a child with systemic lupus erythematosus.

K B Lillquist, J Dyerberg, M Krogh-Jensen.   

Abstract

This report describes a patient with active system lupus erythematosus (SLE), who developed haemorrhagic diathesis due to a lowering of plasma factor II activity. No evidence was found suggesting a plasma inhibitor of factor II. The present case indicates that in some patients with SLE, factor II activity may be low or completely absent due to impairment of factor II synthesis, further that prednisone, but not azathioprine, may ameliorate this defect.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 676741     DOI: 10.1111/j.1651-2227.1978.tb16366.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  5 in total

1.  Lupus anticoagulant after measles.

Authors:  W Muntean; W Petek
Journal:  Eur J Pediatr       Date:  1980-08       Impact factor: 3.183

2.  Lupus anticoagulant-hypoprothrombinemia in healthy adult.

Authors:  Choon Hae Chung; Chi Young Park
Journal:  Korean J Intern Med       Date:  2008-09       Impact factor: 2.884

3.  Steady improvement of prothrombin levels after cyclophosphamide therapy in pediatric lupus anticoagulant hypoprothrombinemia syndrome (LAHPS).

Authors:  Andrea Taddio; AnneMarie C Brescia; Loredana Lepore; Carlos D Rose'
Journal:  Clin Rheumatol       Date:  2007-05-22       Impact factor: 2.980

Review 4.  Transient antiphospholipid antibodies associated with acute infections in children: a report of three cases and a review of the literature.

Authors:  H Mizumoto; T Maihara; E Hiejima; M Shiota; A Hata; S Seto; T Atsumi; T Koike; D Hata
Journal:  Eur J Pediatr       Date:  2006-03-22       Impact factor: 3.183

5.  Lupus anticoagulant hypoprothrombinemia syndrome associated with systemic lupus erythematosus in children: report of two cases and systematic review of the literature.

Authors:  Rakesh Kumar Pilania; Deepti Suri; Ankur Kumar Jindal; Narender Kumar; Avinash Sharma; Praveen Sharma; Sandesh Guleria; Amit Rawat; Jasmina Ahluwalia; Surjit Singh
Journal:  Rheumatol Int       Date:  2018-08-11       Impact factor: 3.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.